
1. gut liver. 2017 mar 15;11(2):270-275. doi: 10.5009/gnl16163.

clinical characteristics treatment outcome peginterferon plus ribavirin in
patients infected genotype 6 hepatitis c virus korea: multicenter
study.

shin sr(1)(2), kim ys(3), lim ys(4), lee js(5), lee jw(6), kim sm(7), jeong
sh(8), sohn jh(9), lee ms(10), park sh(10).

author information: 
(1)health care center, samsung changwon hospital, sungkyunkwan university school 
of medicine, changwon, korea.
(2)department internal medicine, kangwon national university college of
medicine, chuncheon, korea.
(3)department internal medicine, soonchunhyang university college medicine,
bucheon, korea.
(4)department internal medicine, asan medical center, university ulsan
college medicine, seoul, korea.
(5)department internal medicine, inje university ilsan paik hospital, inje
university college medicine, goyang, korea.
(6)department internal medicine, inha university school medicine, incheon, 
korea.
(7)department internal medicine, gimpo woori hospital, gimpo, korea.
(8)department internal medicine, seoul national university bundang hospital,
seongnam, korea.
(9)department internal medicine, hanyang university guri hospital, hanyang
university college medicine, guri, korea.
(10)department internal medicine, hallym university kangnam sacred heart
hospital, seoul, korea.

background/aims: limited geographic distribution, 
insufficient data regarding hepatitis c virus (hcv) genotype 6 korea. this
study aimed investigate clinical characteristics available treatment
outcomes patients genotype 6 hcv korea.
methods: 2004 2014, data collected korean patients infected
with genotype 6 hcv eight hospitals.
results: thirty-two patients genotype 6 hcv. median age 44 years, and
6c common subtype. baseline median alanine transaminase level
was 88 (21 1,019) iu/ml, hcv rna level 1,405,000 (96,500 to
28,844,529) iu/ml. twenty-five patients treated peginterferon (peg-ifn)
and ribavirin. three follow-up losses occurred. additionally, 13 patients
attained sustained virologic response (svr), seven patients relapsed, two
patients exhibited null response. svr rates 40% 75% 24-
and 48-week treatments, respectively, five six patients 
achieved rapid virologic response (rvr) attained svr.
conclusions: korean patients infected genotype 6 hcv relatively young,
and 6c common subtype. treated peg-ifn ribavirin, the
svr rate 52%. similar genotypes, longer duration treatment 
attainment rvr important svr.

doi: 10.5009/gnl16163 
pmcid: pmc5347652
pmid: 27728965  [indexed medline]

